Review



cfda se  (Beyotime)


Bioz Verified Symbol Beyotime is a verified supplier
Bioz Manufacturer Symbol Beyotime manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Beyotime cfda se
    Cfda Se, supplied by Beyotime, used in various techniques. Bioz Stars score: 96/100, based on 367 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cfda+se/pmc13059000-133-15-17?v=Beyotime
    Average 96 stars, based on 367 article reviews
    cfda se - by Bioz Stars, 2026-07
    96/100 stars

    Images



    Similar Products

    96
    MedChemExpress cfda se
    In vitro therapeutic effect of aCD47-CATE. (A) The cell viability of Hepa1-6 cells after different treatments (100 μg/mL), as determined by CCK-8 assay (n = 5). (B) Confocal laser scanning microscopy (CLSM) images of TUNEL staining (red) in Hepa1-6 cells. Nuclei were counterstained with DAPI (blue). Scale bar = 50 μm. (C) Quantitative analysis of the TUNEL-positive cells from (B). Data are presented as mean ± SD (n = 3). (D) Flow cytometry analysis of apoptosis in Hepa1-6 cells after different treatments (n = 3). (E) Flow cytometric analysis of the M1 macrophage marker CD80 in RAW264.7 cells after co-culture with conditioned media from the treated Hepa1-6 cells. (F) CLSM images showing the infiltration of <t>CFDA-SE-labeled</t> M1 macrophages (green) into Hepa1-6 tumor spheroids. Scale bar = 200 μm. (G) Quantitative analysis of the fluorescence intensity of infiltrated macrophages in (F). Data are presented as mean ± SD (n = 3). ns P > 0.05; ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001,∗∗∗∗p < 0.0001.
    Cfda Se, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cfda+se/pmc13054091-348-7-8?v=MedChemExpress
    Average 96 stars, based on 1 article reviews
    cfda se - by Bioz Stars, 2026-07
    96/100 stars
      Buy from Supplier

    96
    Beyotime cfda se
    In vitro therapeutic effect of aCD47-CATE. (A) The cell viability of Hepa1-6 cells after different treatments (100 μg/mL), as determined by CCK-8 assay (n = 5). (B) Confocal laser scanning microscopy (CLSM) images of TUNEL staining (red) in Hepa1-6 cells. Nuclei were counterstained with DAPI (blue). Scale bar = 50 μm. (C) Quantitative analysis of the TUNEL-positive cells from (B). Data are presented as mean ± SD (n = 3). (D) Flow cytometry analysis of apoptosis in Hepa1-6 cells after different treatments (n = 3). (E) Flow cytometric analysis of the M1 macrophage marker CD80 in RAW264.7 cells after co-culture with conditioned media from the treated Hepa1-6 cells. (F) CLSM images showing the infiltration of <t>CFDA-SE-labeled</t> M1 macrophages (green) into Hepa1-6 tumor spheroids. Scale bar = 200 μm. (G) Quantitative analysis of the fluorescence intensity of infiltrated macrophages in (F). Data are presented as mean ± SD (n = 3). ns P > 0.05; ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001,∗∗∗∗p < 0.0001.
    Cfda Se, supplied by Beyotime, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cfda+se/pmc13059000-133-15-17?v=Beyotime
    Average 96 stars, based on 1 article reviews
    cfda se - by Bioz Stars, 2026-07
    96/100 stars
      Buy from Supplier

    86
    Yeasen Biotechnology succinimidyl ester cfda se
    Neutralization of merozoites. A Purification of infected erythrocytes using the Percoll separation solution, displaying infected (black arrow) and normal (red arrow) erythrocytes. B Confocal fluorescent images of merozoites (blue), PECm-Allicin@LM (red), and their colocalization (purple). Scale bar = 50 μm. C Representative scatter plots of Hoechst <t>33342/CFDA-SE</t> for the invasion test of merozoites and normal erythrocytes after drug treatment. D Intrusion rate (the percentage of cells in the Q2 area in each group relative to that in the Q2 area in the Model group). Data are presented as mean ± SEM ( n = 3), * P < 0.05. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
    Succinimidyl Ester Cfda Se, supplied by Yeasen Biotechnology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cfda+se/pmc13049907-64-3-9?v=Yeasen+Biotechnology
    Average 86 stars, based on 1 article reviews
    succinimidyl ester cfda se - by Bioz Stars, 2026-07
    86/100 stars
      Buy from Supplier

    96
    MedChemExpress cfse
    Neutralization of merozoites. A Purification of infected erythrocytes using the Percoll separation solution, displaying infected (black arrow) and normal (red arrow) erythrocytes. B Confocal fluorescent images of merozoites (blue), PECm-Allicin@LM (red), and their colocalization (purple). Scale bar = 50 μm. C Representative scatter plots of Hoechst <t>33342/CFDA-SE</t> for the invasion test of merozoites and normal erythrocytes after drug treatment. D Intrusion rate (the percentage of cells in the Q2 area in each group relative to that in the Q2 area in the Model group). Data are presented as mean ± SEM ( n = 3), * P < 0.05. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
    Cfse, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cfda+se/pm42116089-80-7-8?v=MedChemExpress
    Average 96 stars, based on 1 article reviews
    cfse - by Bioz Stars, 2026-07
    96/100 stars
      Buy from Supplier

    96
    MedChemExpress carboxyfluorescein succinimidyl ester
    Antigen-dependent effector activation of FAP-CAR-NK cells against engineered FAP-positive target cells. ( A ) Flow-cytometric validation of surface FAP expression in engineered K562-FAP-Luc cells. ( B ) Luciferase-based cytotoxicity assay comparing untransduced NK cells and FAP-CAR-NK cells against K562-Luc and K562-FAP-Luc target cells at the indicated E:T ratio after 12 h co-culture. ( C ) Representative flow-cytometric analysis and quantification of CD107a surface expression in untransduced NK cells and FAP-CAR-NK cells after stimulation with K562-FAP-Luc target cells, after 4 h co-culture. ( D ) Multiplex CBA quantification of TNF-α, IFN-γ, granzyme B, and perforin in co-culture supernatants after 4 h stimulation with K562-FAP-Luc target cells. ( E ) <t>CFSE-based</t> proliferation analysis of untransduced NK cells and FAP-CAR-NK cells after 48 h co-culture with K562-FAP-Luc target cells. ( F ) Representative flow-cytometric analysis and quantification of TIM-3, PD-1, and LAG-3 expression in untransduced NK cells and FAP-CAR-NK cells after co-culture with K562-FAP-Luc target cells. Data are presented as mean ± SEM from three independent donor-derived experiments ( n = 3). * p < 0.05, *** p < 0.001, ns, not significant.
    Carboxyfluorescein Succinimidyl Ester, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cfda+se/pmc13164303-220-9-13?v=MedChemExpress
    Average 96 stars, based on 1 article reviews
    carboxyfluorescein succinimidyl ester - by Bioz Stars, 2026-07
    96/100 stars
      Buy from Supplier

    96
    MedChemExpress pbs
    Antigen-dependent effector activation of FAP-CAR-NK cells against engineered FAP-positive target cells. ( A ) Flow-cytometric validation of surface FAP expression in engineered K562-FAP-Luc cells. ( B ) Luciferase-based cytotoxicity assay comparing untransduced NK cells and FAP-CAR-NK cells against K562-Luc and K562-FAP-Luc target cells at the indicated E:T ratio after 12 h co-culture. ( C ) Representative flow-cytometric analysis and quantification of CD107a surface expression in untransduced NK cells and FAP-CAR-NK cells after stimulation with K562-FAP-Luc target cells, after 4 h co-culture. ( D ) Multiplex CBA quantification of TNF-α, IFN-γ, granzyme B, and perforin in co-culture supernatants after 4 h stimulation with K562-FAP-Luc target cells. ( E ) <t>CFSE-based</t> proliferation analysis of untransduced NK cells and FAP-CAR-NK cells after 48 h co-culture with K562-FAP-Luc target cells. ( F ) Representative flow-cytometric analysis and quantification of TIM-3, PD-1, and LAG-3 expression in untransduced NK cells and FAP-CAR-NK cells after co-culture with K562-FAP-Luc target cells. Data are presented as mean ± SEM from three independent donor-derived experiments ( n = 3). * p < 0.05, *** p < 0.001, ns, not significant.
    Pbs, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cfda+se/pmc13115928-155-4-9?v=MedChemExpress
    Average 96 stars, based on 1 article reviews
    pbs - by Bioz Stars, 2026-07
    96/100 stars
      Buy from Supplier

    96
    Beyotime carboxyfluorescein diacetate succinimidyl ester
    Antigen-dependent effector activation of FAP-CAR-NK cells against engineered FAP-positive target cells. ( A ) Flow-cytometric validation of surface FAP expression in engineered K562-FAP-Luc cells. ( B ) Luciferase-based cytotoxicity assay comparing untransduced NK cells and FAP-CAR-NK cells against K562-Luc and K562-FAP-Luc target cells at the indicated E:T ratio after 12 h co-culture. ( C ) Representative flow-cytometric analysis and quantification of CD107a surface expression in untransduced NK cells and FAP-CAR-NK cells after stimulation with K562-FAP-Luc target cells, after 4 h co-culture. ( D ) Multiplex CBA quantification of TNF-α, IFN-γ, granzyme B, and perforin in co-culture supernatants after 4 h stimulation with K562-FAP-Luc target cells. ( E ) <t>CFSE-based</t> proliferation analysis of untransduced NK cells and FAP-CAR-NK cells after 48 h co-culture with K562-FAP-Luc target cells. ( F ) Representative flow-cytometric analysis and quantification of TIM-3, PD-1, and LAG-3 expression in untransduced NK cells and FAP-CAR-NK cells after co-culture with K562-FAP-Luc target cells. Data are presented as mean ± SEM from three independent donor-derived experiments ( n = 3). * p < 0.05, *** p < 0.001, ns, not significant.
    Carboxyfluorescein Diacetate Succinimidyl Ester, supplied by Beyotime, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cfda+se/10__1016_slash_j__vetpar__2026__110762-105-31-35?v=Beyotime
    Average 96 stars, based on 1 article reviews
    carboxyfluorescein diacetate succinimidyl ester - by Bioz Stars, 2026-07
    96/100 stars
      Buy from Supplier

    96
    MedChemExpress cfda-se
    Antigen-dependent effector activation of FAP-CAR-NK cells against engineered FAP-positive target cells. ( A ) Flow-cytometric validation of surface FAP expression in engineered K562-FAP-Luc cells. ( B ) Luciferase-based cytotoxicity assay comparing untransduced NK cells and FAP-CAR-NK cells against K562-Luc and K562-FAP-Luc target cells at the indicated E:T ratio after 12 h co-culture. ( C ) Representative flow-cytometric analysis and quantification of CD107a surface expression in untransduced NK cells and FAP-CAR-NK cells after stimulation with K562-FAP-Luc target cells, after 4 h co-culture. ( D ) Multiplex CBA quantification of TNF-α, IFN-γ, granzyme B, and perforin in co-culture supernatants after 4 h stimulation with K562-FAP-Luc target cells. ( E ) <t>CFSE-based</t> proliferation analysis of untransduced NK cells and FAP-CAR-NK cells after 48 h co-culture with K562-FAP-Luc target cells. ( F ) Representative flow-cytometric analysis and quantification of TIM-3, PD-1, and LAG-3 expression in untransduced NK cells and FAP-CAR-NK cells after co-culture with K562-FAP-Luc target cells. Data are presented as mean ± SEM from three independent donor-derived experiments ( n = 3). * p < 0.05, *** p < 0.001, ns, not significant.
    Cfda Se, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cfda+se/medchemexpress___hy-d0938?v=MedChemExpress
    Average 96 stars, based on 1 article reviews
    cfda-se - by Bioz Stars, 2026-07
    96/100 stars
      Buy from Supplier

    Image Search Results


    In vitro therapeutic effect of aCD47-CATE. (A) The cell viability of Hepa1-6 cells after different treatments (100 μg/mL), as determined by CCK-8 assay (n = 5). (B) Confocal laser scanning microscopy (CLSM) images of TUNEL staining (red) in Hepa1-6 cells. Nuclei were counterstained with DAPI (blue). Scale bar = 50 μm. (C) Quantitative analysis of the TUNEL-positive cells from (B). Data are presented as mean ± SD (n = 3). (D) Flow cytometry analysis of apoptosis in Hepa1-6 cells after different treatments (n = 3). (E) Flow cytometric analysis of the M1 macrophage marker CD80 in RAW264.7 cells after co-culture with conditioned media from the treated Hepa1-6 cells. (F) CLSM images showing the infiltration of CFDA-SE-labeled M1 macrophages (green) into Hepa1-6 tumor spheroids. Scale bar = 200 μm. (G) Quantitative analysis of the fluorescence intensity of infiltrated macrophages in (F). Data are presented as mean ± SD (n = 3). ns P > 0.05; ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001,∗∗∗∗p < 0.0001.

    Journal: Materials Today Bio

    Article Title: Macrophage exosome-engineered nanoplatform with pH-responsive ratiometric photoacoustic and NIR-II fluorescence imaging for guided photothermal immunotherapy of hepatocellular carcinoma

    doi: 10.1016/j.mtbio.2026.103058

    Figure Lengend Snippet: In vitro therapeutic effect of aCD47-CATE. (A) The cell viability of Hepa1-6 cells after different treatments (100 μg/mL), as determined by CCK-8 assay (n = 5). (B) Confocal laser scanning microscopy (CLSM) images of TUNEL staining (red) in Hepa1-6 cells. Nuclei were counterstained with DAPI (blue). Scale bar = 50 μm. (C) Quantitative analysis of the TUNEL-positive cells from (B). Data are presented as mean ± SD (n = 3). (D) Flow cytometry analysis of apoptosis in Hepa1-6 cells after different treatments (n = 3). (E) Flow cytometric analysis of the M1 macrophage marker CD80 in RAW264.7 cells after co-culture with conditioned media from the treated Hepa1-6 cells. (F) CLSM images showing the infiltration of CFDA-SE-labeled M1 macrophages (green) into Hepa1-6 tumor spheroids. Scale bar = 200 μm. (G) Quantitative analysis of the fluorescence intensity of infiltrated macrophages in (F). Data are presented as mean ± SD (n = 3). ns P > 0.05; ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001,∗∗∗∗p < 0.0001.

    Article Snippet: RAW264.7 cells were labeled with 1 μM CFDA-SE (Medchemexpress), added to the 96-well plate, and co-cultured with the spheroids for 6 h. The cell pellet was aspirated, fixed with 4% paraformaldehyde, stained with DAPI for 5 min, and observed under a fluorescence microscope (Leica, 3D thunder).

    Techniques: In Vitro, CCK-8 Assay, Confocal Laser Scanning Microscopy, TUNEL Assay, Staining, Flow Cytometry, Marker, Co-Culture Assay, Labeling, Fluorescence

    Neutralization of merozoites. A Purification of infected erythrocytes using the Percoll separation solution, displaying infected (black arrow) and normal (red arrow) erythrocytes. B Confocal fluorescent images of merozoites (blue), PECm-Allicin@LM (red), and their colocalization (purple). Scale bar = 50 μm. C Representative scatter plots of Hoechst 33342/CFDA-SE for the invasion test of merozoites and normal erythrocytes after drug treatment. D Intrusion rate (the percentage of cells in the Q2 area in each group relative to that in the Q2 area in the Model group). Data are presented as mean ± SEM ( n = 3), * P < 0.05. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)

    Journal: International Journal of Pharmaceutics: X

    Article Title: Allicin-based biomimetic nanoparticles of the erythrocyte membrane for the delivery of lumefantrine to enhance its antimalarial effect

    doi: 10.1016/j.ijpx.2026.100487

    Figure Lengend Snippet: Neutralization of merozoites. A Purification of infected erythrocytes using the Percoll separation solution, displaying infected (black arrow) and normal (red arrow) erythrocytes. B Confocal fluorescent images of merozoites (blue), PECm-Allicin@LM (red), and their colocalization (purple). Scale bar = 50 μm. C Representative scatter plots of Hoechst 33342/CFDA-SE for the invasion test of merozoites and normal erythrocytes after drug treatment. D Intrusion rate (the percentage of cells in the Q2 area in each group relative to that in the Q2 area in the Model group). Data are presented as mean ± SEM ( n = 3), * P < 0.05. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)

    Article Snippet: 5–6(and 6)-carboxyfuorescein diacetate, succinimidyl ester (CFDA-SE) was purchased from Yeasen Biotechnology (Shanghai) Co., Ltd. (China).

    Techniques: Neutralization, Purification, Infection

    Antigen-dependent effector activation of FAP-CAR-NK cells against engineered FAP-positive target cells. ( A ) Flow-cytometric validation of surface FAP expression in engineered K562-FAP-Luc cells. ( B ) Luciferase-based cytotoxicity assay comparing untransduced NK cells and FAP-CAR-NK cells against K562-Luc and K562-FAP-Luc target cells at the indicated E:T ratio after 12 h co-culture. ( C ) Representative flow-cytometric analysis and quantification of CD107a surface expression in untransduced NK cells and FAP-CAR-NK cells after stimulation with K562-FAP-Luc target cells, after 4 h co-culture. ( D ) Multiplex CBA quantification of TNF-α, IFN-γ, granzyme B, and perforin in co-culture supernatants after 4 h stimulation with K562-FAP-Luc target cells. ( E ) CFSE-based proliferation analysis of untransduced NK cells and FAP-CAR-NK cells after 48 h co-culture with K562-FAP-Luc target cells. ( F ) Representative flow-cytometric analysis and quantification of TIM-3, PD-1, and LAG-3 expression in untransduced NK cells and FAP-CAR-NK cells after co-culture with K562-FAP-Luc target cells. Data are presented as mean ± SEM from three independent donor-derived experiments ( n = 3). * p < 0.05, *** p < 0.001, ns, not significant.

    Journal: International Journal of Molecular Sciences

    Article Title: Proof-of-Concept Evaluation of Primary Human FAP-CAR-NK Cells Targeting Activated Fibroblasts in Pulmonary Fibrosis

    doi: 10.3390/ijms27094128

    Figure Lengend Snippet: Antigen-dependent effector activation of FAP-CAR-NK cells against engineered FAP-positive target cells. ( A ) Flow-cytometric validation of surface FAP expression in engineered K562-FAP-Luc cells. ( B ) Luciferase-based cytotoxicity assay comparing untransduced NK cells and FAP-CAR-NK cells against K562-Luc and K562-FAP-Luc target cells at the indicated E:T ratio after 12 h co-culture. ( C ) Representative flow-cytometric analysis and quantification of CD107a surface expression in untransduced NK cells and FAP-CAR-NK cells after stimulation with K562-FAP-Luc target cells, after 4 h co-culture. ( D ) Multiplex CBA quantification of TNF-α, IFN-γ, granzyme B, and perforin in co-culture supernatants after 4 h stimulation with K562-FAP-Luc target cells. ( E ) CFSE-based proliferation analysis of untransduced NK cells and FAP-CAR-NK cells after 48 h co-culture with K562-FAP-Luc target cells. ( F ) Representative flow-cytometric analysis and quantification of TIM-3, PD-1, and LAG-3 expression in untransduced NK cells and FAP-CAR-NK cells after co-culture with K562-FAP-Luc target cells. Data are presented as mean ± SEM from three independent donor-derived experiments ( n = 3). * p < 0.05, *** p < 0.001, ns, not significant.

    Article Snippet: Untransduced NK cells and FAP-CAR-NK cells were labeled with carboxyfluorescein succinimidyl ester (CFSE; MCE, #HY-D0938) according to the manufacturer’s instructions.

    Techniques: Activation Assay, Biomarker Discovery, Expressing, Luciferase, Cytotoxicity Assay, Co-Culture Assay, Multiplex Assay, Derivative Assay